Primary lateral sclerosis

Muscle and Nerve

Volumn 35, Issue 3, 2007, Pages 291-302

  Singer, Mike A ^a   Statland, Jeffrey M ^b   Wolfe, Gil I ^a   Barohn, Richard J ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Motor neuron disease; Primary lateral sclerosis

Indexed keywords

ALPHA TOCOPHEROL; AMITRIPTYLINE; ASCORBIC ACID; BACLOFEN; BENZATROPINE MESILATE; BENZODIAZEPINE; BETA CAROTENE; BOTULINUM TOXIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLYCOPYRRONIUM BROMIDE; HYOSCYAMINE; RILUZOLE; SCOPOLAMINE; TIZANIDINE; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ELECTRODIAGNOSIS; EMOTIONAL INCONTINENCE; EVOKED MUSCLE RESPONSE; EVOKED SOMATOSENSORY RESPONSE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYPERSALIVATION; LABORATORY DIAGNOSIS; MOTONEURON; MOTOR NEURON DISEASE; MUSCLE BIOPSY; NEUROIMAGING; OCCUPATIONAL THERAPY; PHYSIOTHERAPY; PRIMARY LATERAL SCLEROSIS; PRIORITY JOURNAL; PSEUDOBULBAR PALSY; PYRAMIDAL SIGN; REVIEW; SYMPTOMATOLOGY;

AGE OF ONSET; BRAIN; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; EFFERENT PATHWAYS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOTOR NEURON DISEASE; MOTOR NEURONS; PYRAMIDAL TRACTS;

EID: 33847624128     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20728     Document Type: Review

References (75)

1. Appelbaum JS, Roos RP, Salazar-Grueso EF, Buchman A, Iannaccone S, Glantz R, et al. Intrafamilial heterogeneity in hereditary motor neuron disease. Neurology 1992;42:1488-1492.
2. Beal MF, Richardson EP. Primary lateral sclerosis: a case report. Arch Neurol 1981;38:630-633.
3. Behan WM, Maia M. Strumpell's familial spastic paraplegia: genetics and neuropathology. J Neurol Neurosurg Psychiatry 1974;37:8-20.
4. Brooks BR. El Escorial World Federaton of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124(suppl):96-107.
5. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.
6. Brown WF, Ebers GC, Hudson AJ, Pringle CE, Veitch J. Motor-evoked responses in primary lateral sclerosis. Muscle Nerve 1992;15:626-629.
7. Brownell B, Oppenheimer DR, Hugher JT. The central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry 1970;33:338-357.
8. Brugman F, Wokke JH, Scheffer H, Versteeg MH, Sistermans EA, van den Berg LH. Spastin mutations in sporadic adult-onset upper motor neuron syndromes. Ann Neurol 2005;58: 865-869.
9. Brugman F, Wokke JH, Vianney de Jong JM, Franssen H, Faber CG, Van den Berg LH. Primary lateral sclerosis as a phenotypic manifestation of familial ALS. Neurology 2005;64: 1778-1779.
10. Bruyn RP, Koelman JH, Troost D, de Jong JM. Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis. J Neurol Neurosurg Psychiatry 1995;58:742-744.
11. Buzzard EF, Barnes S. A case of chronic progressive double hemiplegia. Rev Neurol Psychiatry 1906;4:182-191.
12. Caselli RJ, Smith BE, Osborne D. Primary lateral sclerosis: a neuropsychological study. Neurology 1995;45:2005-2009.
13. Chan S, Kaufmann P, Shungu DC, Mitsumoto H. Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron. Neuroimag Clin N Am 2003;13:307-326.
14. Chan S, Shungu DC, Douglas-Akinwande A, Lange DJ, Rowland LP. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. Radiology 1999;212:763-769.
15. Charcot JM. Lecture XVI: Transverse myelitis and spasmodic tabes dorsalis. In: Lectures on the localization of cerebral and spinal diseases. London: New Sydenham Society; 1883. p 299-300.
16. de Koning I, van Doom PA, van Dongen HR. Slowly progressive isolated dysarthria: longitudinal course, speech features, and neuropsychological deficits. J Neurol 1997;244:664-667.
17. Desai J, Swash M. Primary lateral sclerosis associated with IgM paraproteinemia. Neuromusc Disord 1998;9:38-40.
18. Erb WH. Spastic and syphilitic paralysis. Lancet 1902;ii:969-974.
19. Eymard-Pierre E, Yamanaka K, Haeussler M, Kress W, Gauthier-Barichard F, Combes P, et al. Novel missense mutation in ALS2 gene results in infantile ascending hereditary spastic paralysis. Ann Neurol 2006;59:976-980.
20. Felice KJ, North WA. Creatine kinase values in amyotrophic lateral sclerosis. J Neurol Sci 1998;160(suppl):S30-S32.
21. Fink JK. The hereditary spastic paraplegias: nine genes and counting. Arch Neurol 2003;60:1045-1049.
22. Fink JK, Ranier S. Hereditary spastic paraplegia: spastin phenotype and function. Arch Neurol 2004;61:830-833.
23. Fisher CM. Pure spastic paraplegia of corticospinal origin. Can J Neurol Sci 1977;4:251-258.
24. Floeter MK, Zhai P, Saigal R, Kim Y, Statland J. Motor neuron firing dysfunction in spastic patients with primary lateral sclerosis. J Neurophysiol 2005;94:919-927.
25. Forsyth PA, Dalmau J, Graus F, Cwik V, Rosenblum MK, Posner JB. Motor neuron syndromes in cancer patients. Ann Neurol 1997;41:722-730.
26. Gastaut JL, Bartolomei F. Mills' syndrome: ascending (or descending) progressive hemiplegia: a hemiplegic form of primary lateral sclerosis? J Neurol Neurosurg Psychiatry 1994; 57:1280-1281.
27. Gastaut JL, Michel B, Figarella-Branger D, Somma-Mauvais H. Chronic progressive spinobulbar spasticity: a rare form of primary lateral sclerosis. Arch Neurol 1988;45:509-513.
28. Giess R, Naumann M, Werner E, Riemann R, Beck M, Puls I, et al. Injections of botulinum toxin A into salivary glands improve sialorrhoea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2000;69:121-123.
29. Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, et al. The natural history of primary lateral sclerosis. Neurology 2006;66:647-653.
30. Gordon PH, Pinto M, Mitsumoto H, Kaufmann P, Rowland LP. The clinical manifestations of primary lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004; 5:112.
31. Gros-Louis F, Meijer IA, Hand CK, Dube MP, MacGregor DL, Seni MH, et al. An ALS2 gene mutation causes hereditary spastic paraplegia in a Pakistani kindred. Ann Neurol 2003; 53:144-145.
32. Grunnet ML, Leicher C, Zimmerman A, Zalneraitis E, Barwick M. Primary lateral sclerosis in a child. Neurology 1989; 39:1530-1532.
33. Hand CK, Devon RS, Gros-Louis F, Rochefort D, Khoris J, Meininger V, et al. Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosis. Arch Neurol 2003;60:1768-1771.
34. Holmes GL, Shaywitz BA. Strumpell's pure familial spastic paraplegia: case study and review of the literature. J Neurol Neurosurg Psychiatry 1977;40:1003-1008.
35. Ilzecka J, Stelmasiak Z. Creatine kinase activity in amyotrophic lateral sclerosis patients. Neurol Sci 2003;24:286-287.
36. Koga H, Ozeki T, Makiura Y, Nokura K, Yamamoto H, Matsumoto Y, et al. Sporadic motor neuron disease with marked frontotemporal atrophy: an autopsied case mimicking primary lateral sclerosis. Neuropathology 2003;23:A40.
37. Kojan S, Goodwin WE, Bryan WW, Nations SP, Burns DK, Barohn RJ, et al. Clinical and laboratory features of primary lateral sclerosis. J Child Neurol 2000;15:200.
38. Konagaya M, Sakai M, Matsuoka Y, Konagaya Y, Haschizume Y. Upper motor neuron predominant degeneration with frontal and temporal lobe atrophy. Acta Neuropathol 1998;96: 532-536.
39. Kress JA, Kuhnlein P, Winter P, Ludolph AC, Kassubek J, et al. Novel mutation in the ALS2 gene in juvenile amyotrophic lateral sclerosis. Ann Neurol 2005;58:800-803.
40. Kuipers-Upmeijer J, de Jager AEJ, Hew JM, Snoek JW, van Weerden TW. Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings. J Neurol Neurosurg Psychiatry 2001;71:615-620.
41. Le Forestier N, Maisonobe T, Piquard A, Rivaud S, Creiver-Buchman L, Slachas F, et al. Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature. Brain 2001;124:1989-1999.
42. Le Forestier N, Maisonobe T, Spelle L, Lesort A, Salachas F, Lacomblez L, et al. Primary lateral sclerosis: further clarification. J Neurol Sci 2001;185:95-100.
43. Lima AF, Evangelista T, de Carvalho M. Increased creatine kinase and spontaneous activity on electromyography in amyotrophic lateral sclerosis. Electromyogr Clin Neurophysiol 2003;43:189-192.
44. Lipp A, Trottenberg T, Schink T, Kupsch A, Arnold G. A randomized trial of botulinum toxin A for treatment of drooling. Neurology 2003;59:1077-1079.
45. Lo Giudice M, Neri M, Falco M, Sturnio M, Calzolari E, Di Benedetto D, et al. A missense mutation in the coiled-coil domain of the KIF5A gene and late-onset hereditary spastic paraplegia. Arch Neurol 2006;63:284-287.
46. Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002;59:177-179.
47. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003;60:1094-1097.
48. McDermott C, White K, Bushby K, Shaw P. Hereditary spastic paraparesis: a review of new developments. J Neurol Neurosurg Psychiatry 2000;69:150-160.
49. McDermott CJ, Burness CE, Kirby J, Cox LE, Rao DG, Hewamadduma C, et al. Clinical features of hereditary spastic paraplegia due to spastin mutation. Neurology 2006;67:45-51.
50. Mochizuki A, Komatsuzaki Y, Iwamoto H, Shoji S. Frontotemporal dementia with ubiquitinated neuronal inclusions presenting with primary lateral sclerosis and parkinsonism: clinicopathological report of an autopsy case. Acta Neuropathol 2004;107:377-380.
51. Panzeri C, De Palma C, Martinuzzi A, Daga A, De Polo G, Bresolin N, et al. The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function. Brain 2006;129:1710-1719.
52. Pohl C, Block W, Traber F, Schmidt S, Pels H, Grothe C, et al. Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients. J Neurol Sci 2001;190:21-27.
53. Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis: clinical features, neuropathology and diagnostic criteria. Brain 1992;115:495-520.
54. Rowland L. How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean-Martin Charcot. Arch Neurol 2001;58:512-515.
55. Rowland LP. Primary lateral sclerosis: disease, syndrome, both or neither? J Neurol Sci 1999;170:1-4.
56. Rowland LP. Primary lateral sclerosis, hereditary spastic paraplegia, and mutations in the alsin gene: historical background for the First International Conference. Amyotroph Lateral Scler Other Motor Neuron Disord 2005;6:67-76.
57. Russo LS. Clinical and electrophysiological studies in primary lateral sclerosis. Arch Neurol 1982;39:662-664.
58. Singer MA, Kojan S, Barohn R, Herbelin L, Nations SP, Trivedi JR, et al. Primary lateral sclerosis: clinical and laboratory features in 25 patients. J Clin Neuromusc Dis 2005;7:1-9.
59. Smith CD. Serial MRI finding in a case of primary lateral sclerosis. Neurology 2002;7:647-649.
60. Sotaniemi KA, Myllyla W. Primary lateral sclerosis: a debated entity. Acta Neurol Scand 1985;71:334-336.
61. Spiller WG. Primary degeneration of the pyramidal tracts: a study of eight cases with necropsy. Univ Penn Med Bull 1905; 17:390-395, 407-414.
62. Starck FM, Moersch FP. Primary lateral sclerosis: a distinct clinical entity. J Nerv Ment Dis 1945;102:332-337.
63. Strong MJ. Progress in clinical neurosciences: the evidence for ALS as a multisystems disorder of limited phenotypic expression. Can J Neurol Sci 2001;28:283-298.
64. Sugihara H, Horiuchi M, Kamo T, Fujisawa K, Abe M, Sakiyama T, et al. A case of primary lateral sclerosis taking a prolonged clinical course with dementia and having an unusual dendrtitc ballooning. Neuropathology 1999;19:77-84.
65. Suhy J, Miller RG, Rule R, Schliff N, Licht J, Dronsky V, et al. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology 2002;58:773-779.
66. Swank RL, Putnam TJ. Amyotrophic lateral sclerosis and related conditions. Arch Neurol Psychiatry 1943;49:141-177.
67. Swash M, Desai J, Misra VP. What is primary lateral sclerosis? J Neurol Sci 1999;170:5-10.
68. Tan CF, Kakita A, Piao YS, Kikugawa K, Endo K, Tanaka M, et al. Primary lateral sclerosis: a rare upper-motor-predominant form of amyotrophic lateral sclerosis often accompanied by frontotemporal lobar degeneration with ubiquitinated neuronal inclusions? Report of an autopsy case and a review of the literature. Acta Neuropathol 2003;105:615-620.
69. Ulug AM, Greenwald T, Lin MT, Kamal AK, Filippi CG, Zimmerman RD, et al. Diffusion tensor imaging in the diagnosis of primary lateral sclerosis. J Magn Reson Imag 2004; 19:34-39.
70. Watanabe R, Iino M, Honda M, Sano J, Hara M. Primary lateral sclerosis. Neuropathology 1997;17:220-224.
71. Wilson SAK. Amyotropic lateral sclerosis. In: Ninian BA, editor. Neurology. Baltimore: Williams & Wilkins; 1940. p 1015-1016.
72. Worms PM. The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci 2001;191:3-9.
73. Yang Y, Hentati A, Deng HX, Dabbagh O, Sasaki T, Hirano M, et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 2001;29: 160-165.
74. Younger DS, Chou S, Hays AP, Lange DL, Emerson R, Brin M, et al. Primary lateral sclerosis: a clinical diagnosis reemerges. Arch Neurol 1988;45:1304-1307.
75. Zhai P, Pagan F, Statland J, Butman JA, Floeter MK. Primary lateral sclerosis: a heterogeneous disorder composed of different subtypes? Neurology 2003;60:1258-1265.